Studying harms of interventions with an equity lens in randomized trials

Trials. 2024 Jun 21;25(1):403. doi: 10.1186/s13063-024-08239-x.

Abstract

Equity and health equity are fundamental pillars in fostering a just and inclusive society. While equity underscores fairness in resource allocation and opportunity, health equity aims to eradicate avoidable health disparities among social groups. The concept of harms in interventions-undesirable consequences associated with the use of interventions-often varies across populations due to biological and social factors, necessitating a nuanced understanding. An equity lens reveals disparities in harm distribution, urging researchers and policymakers to address these differences in their decision-making processes. Furthermore, interventions, even well-intentioned ones, can inadvertently exacerbate disparities, emphasizing the need for comprehensive harm assessment. Integrating equity considerations in research practices and trial methodologies, through study design or through practices such as inclusive participant recruitment, is pivotal in advancing health equity. By prioritizing interventions that address disparities and ensuring inclusivity in research, we can foster a more equitable healthcare system.

Keywords: Disparity; Equity; Harms; Health equity; Randomized trials.

MeSH terms

  • Health Equity*
  • Health Status Disparities
  • Healthcare Disparities*
  • Humans
  • Patient Selection
  • Randomized Controlled Trials as Topic*
  • Research Design
  • Risk Assessment
  • Risk Factors